87 related articles for article (PubMed ID: 9651170)
1. Identification of a dihydropyridine as a potent alpha1a adrenoceptor-selective antagonist that inhibits phenylephrine-induced contraction of the human prostate.
Wong WC; Chiu G; Wetzel JM; Marzabadi MR; Nagarathnam D; Wang D; Fang J; Miao SW; Hong X; Forray C; Vaysse PJ; Branchek TA; Gluchowski C; Tang R; Lepor H
J Med Chem; 1998 Jul; 41(14):2643-50. PubMed ID: 9651170
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of novel alpha1a adrenoceptor-selective dihydropyridine antagonists for the treatment of benign prostatic hyperplasia.
Nagarathnam D; Wetzel JM; Miao SW; Marzabadi MR; Chiu G; Wong WC; Hong X; Fang J; Forray C; Branchek TA; Heydorn WE; Chang RS; Broten T; Schorn TW; Gluchowski C
J Med Chem; 1998 Dec; 41(26):5320-33. PubMed ID: 9857099
[TBL] [Abstract][Full Text] [Related]
3. RBx 6198: a novel alpha1-adrenoceptor antagonist for the treatment of benign prostatic hyperplasia.
Nanda K; Naruganahalli KS; Gupta S; Malhotra S; Tiwari A; Hegde LG; Jain S; Sinha N; Gupta JB; Chugh A; Anand N; Ray A
Eur J Pharmacol; 2009 Apr; 607(1-3):213-9. PubMed ID: 19239913
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of buflomedil on prostate alpha1A adrenoceptor in the Wistar rat.
Tang LM; Cheng JT; Tong YC
Neurosci Lett; 2004 Sep; 367(2):224-7. PubMed ID: 15331158
[TBL] [Abstract][Full Text] [Related]
5. Mechanistic investigation of the adrenergic induction of ventral prostate hyperplasia in mice.
Marinese D; Patel R; Walden PD
Prostate; 2003 Feb; 54(3):230-7. PubMed ID: 12518328
[TBL] [Abstract][Full Text] [Related]
6. Laboratory assessment of terazosin and alpha-1 blockade in prostatic hyperplasia.
Lepor H; Gup DI; Baumann M; Shapiro E
Urology; 1988 Dec; 32(6 Suppl):21-6. PubMed ID: 2462301
[TBL] [Abstract][Full Text] [Related]
7. Receptor-operated Ca2+ entry mediated by TRPC3/TRPC6 proteins in rat prostate smooth muscle (PS1) cell line.
Thebault S; Zholos A; Enfissi A; Slomianny C; Dewailly E; Roudbaraki M; Parys J; Prevarskaya N
J Cell Physiol; 2005 Jul; 204(1):320-8. PubMed ID: 15672411
[TBL] [Abstract][Full Text] [Related]
8. Alpha1L-adrenoceptors mediate contractions of the isolated mouse prostate.
Gray KT; Ventura S
Eur J Pharmacol; 2006 Jul; 540(1-3):155-61. PubMed ID: 16716294
[TBL] [Abstract][Full Text] [Related]
9. The receptor antagonist picotamide inhibits adrenergic and thromboxane-induced contraction of hyperplastic human prostate smooth muscle.
Hennenberg M; Miljak M; Herrmann D; Strittmatter F; Walther S; Rutz B; Hocaoglu Y; Kunit T; Schreiber A; Andersson KE; Stief CG; Gratzke C
Am J Physiol Renal Physiol; 2013 Nov; 305(10):F1383-90. PubMed ID: 24049147
[TBL] [Abstract][Full Text] [Related]
10. Z-350, a new chimera compound possessing alpha1-adrenoceptor antagonistic and steroid 5alpha-reductase inhibitory actions.
Fukuda Y; Fukuta Y; Higashino R; Ogishima M; Yoshida K; Tamaki H; Takei M
Naunyn Schmiedebergs Arch Pharmacol; 1999 Jun; 359(6):433-8. PubMed ID: 10431752
[TBL] [Abstract][Full Text] [Related]
11. Increased contractile response to phenylephrine in detrusor of patients with bladder outlet obstruction: effect of the alpha1A and alpha1D-adrenergic receptor antagonist tamsulosin.
Bouchelouche K; Andersen L; Alvarez S; Nordling J; Bouchelouche P
J Urol; 2005 Feb; 173(2):657-61. PubMed ID: 15643283
[TBL] [Abstract][Full Text] [Related]
12. KMD-3213, a novel alpha1A-adrenoceptor antagonist, potently inhibits the functional alpha1-adrenoceptor in human prostate.
Moriyama N; Akiyama K; Murata S; Taniguchi J; Ishida N; Yamazaki S; Kawabe K
Eur J Pharmacol; 1997 Jul; 331(1):39-42. PubMed ID: 9274928
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo uroselectivity of B8805-033, an antagonist with high affinity at prostatic alpha1A- vs. alpha1B- and alpha1D-adrenoceptors.
Eltze M; Boer R; Michel MC; Hein P; Testa R; Ulrich WR; Kolassa N; Sanders KH
Naunyn Schmiedebergs Arch Pharmacol; 2001 Jun; 363(6):649-62. PubMed ID: 11414660
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the alpha-adrenoceptor characteristics in human and canine prostate.
Hieble JP; Boyce AJ; Caine M
Fed Proc; 1986 Oct; 45(11):2609-14. PubMed ID: 2428671
[TBL] [Abstract][Full Text] [Related]
15. Effect of KMD-3213, an alpha 1a-adrenoceptor-selective antagonist, on the contractions of rabbit prostate and rabbit and rat aorta.
Yamagishi R; Akiyama K; Nakamura S; Hora M; Masuda N; Matsuzawa A; Murata S; Ujiie A; Kurashina Y; Iizuka K; Kitazawa M
Eur J Pharmacol; 1996 Nov; 315(1):73-9. PubMed ID: 8960867
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of an alpha1a-adrenergic receptor subtype-selective antagonist from BE2254.
Chiu G; Gluchowski C; Forray C
Chem Biol Drug Des; 2006 Jun; 67(6):437-9. PubMed ID: 16882319
[TBL] [Abstract][Full Text] [Related]
17. History and nomenclature of alpha1-adrenoceptors.
Langer SZ
Eur Urol; 1999; 36 Suppl 1():2-6. PubMed ID: 10438241
[TBL] [Abstract][Full Text] [Related]
18. 8-NH2-boldine, an antagonist of alpha1A and alpha1B adrenoceptors without affinity for the alpha1D subtype: structural requirements for aporphines at alpha1-adrenoceptor subtypes.
Ivorra MD; Valiente M; MartÃnez S; Madrero Y; Noguera MA; Cassels BK; Sobarzo EM; D'Ocon P
Planta Med; 2005 Oct; 71(10):897-903. PubMed ID: 16254819
[TBL] [Abstract][Full Text] [Related]
19. Inhibition by tamsulosin of tension responses of human hyperplastic prostate to electrical field stimulation.
Chueh SC; Guh JH; Chen J; Lai MK; Ko FN; Teng CM
Eur J Pharmacol; 1996 Jun; 305(1-3):177-80. PubMed ID: 8813550
[TBL] [Abstract][Full Text] [Related]
20. An investigation of the uroselective properties of four novel alpha(1a)-adrenergic receptor subtype-selective antagonists.
Pulito VL; Li X; Varga SS; Mulcahy LS; Clark KS; Halbert SA; Reitz AB; Murray WV; Jolliffe LK
J Pharmacol Exp Ther; 2000 Jul; 294(1):224-9. PubMed ID: 10871316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
